Free Trial

Charles River Laboratories International (CRL) News Today

→ Top 5 AI Stocks to Buy for 2024 (From Market Moving Trends) (Ad)
Free CRL Stock Alerts
$214.79
-6.83 (-3.08%)
(As of 06/7/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends
June 8 at 9:49 AM | marketbeat.com
Morningstar Investment Services LLC Purchases 51,110 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Morningstar Investment Services LLC grew its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 99.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 102,626 shares of the medi
June 8 at 2:50 AM | americanbankingnews.com
Charles River Laboratories International (NYSE:CRL) Stock Rating Upgraded by StockNews.com
June 7 at 8:40 AM | marketbeat.com
Public Employees Retirement Association of Colorado Sells 37,050 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Public Employees Retirement Association of Colorado reduced its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 43.9% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned
June 7 at 7:40 AM | americanbankingnews.com
Charles River Laboratories International (NYSE:CRL) Coverage Initiated at Mizuho
June 7 at 5:10 AM | americanbankingnews.com
Charles River Laboratories International (NYSE:CRL) Coverage Initiated by Analysts at The Goldman Sachs Group
June 6 at 10:13 PM | marketbeat.com
Charles River Laboratories International (NYSE:CRL) Upgraded to Buy at StockNews.com
StockNews.com upgraded shares of Charles River Laboratories International from a "hold" rating to a "buy" rating in a report on Thursday.
June 6 at 11:57 AM | globenewswire.com
CRL INVESTIGATION ALERT: Johnson Fistel LLP Investigates Charles River Laboratories' Directors and Officers for Breach of Fiduciary Duties
June 6 at 8:43 AM | marketbeat.com
Armistice Capital LLC Sells 120,000 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Armistice Capital LLC decreased its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 76.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 36,000 shares of the medical resea
June 6 at 7:30 AM | marketbeat.com
Charles River Laboratories International (NYSE:CRL) Now Covered by Analysts at The Goldman Sachs Group
The Goldman Sachs Group assumed coverage on shares of Charles River Laboratories International in a research report on Thursday. They issued a "buy" rating and a $290.00 target price on the stock.
June 6 at 12:50 AM | marketbeat.com
Charles River Laboratories International, Inc. (NYSE:CRL) Holdings Raised by Pinebridge Investments L.P.
Pinebridge Investments L.P. lifted its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 23.1% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 100,381 shares of the medical research compa
June 4, 2024 | marketbeat.com
Bell Asset Management Ltd Sells 6,868 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Bell Asset Management Ltd trimmed its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 13.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 43,439 shares of the medi
June 4, 2024 | americanbankingnews.com
Charles River Laboratories International, Inc. (NYSE:CRL) Sees Significant Drop in Short Interest
June 3, 2024 | marketbeat.com
Nicholas Company Inc. Has $16.71 Million Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Nicholas Company Inc. increased its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 17.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 70,681 shares of the medical rese
June 3, 2024 | marketbeat.com
Charles River Laboratories International, Inc. (NYSE:CRL) Position Increased by Meritage Group LP
Meritage Group LP boosted its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 30.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,155,376 shares of the medical re
June 2, 2024 | marketbeat.com
Short Interest in Charles River Laboratories International, Inc. (NYSE:CRL) Drops By 8.4%
Charles River Laboratories International, Inc. (NYSE:CRL - Get Free Report) was the recipient of a significant drop in short interest during the month of May. As of May 15th, there was short interest totalling 1,740,000 shares, a drop of 8.4% from the April 30th total of 1,900,000 shares. Based on an average trading volume of 516,900 shares, the short-interest ratio is presently 3.4 days.
June 2, 2024 | americanbankingnews.com
Charles River Laboratories International, Inc. (NYSE:CRL) Given Consensus Rating of "Moderate Buy" by Brokerages
June 2, 2024 | marketbeat.com
Charles River Laboratories International, Inc. (NYSE:CRL) Given Consensus Rating of "Moderate Buy" by Analysts
Shares of Charles River Laboratories International, Inc. (NYSE:CRL - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the eleven ratings firms that are presently covering the stock, Marketbeat.com reports. Four analysts have rated the stock with a hold recommenda
June 1, 2024 | americanbankingnews.com
Q2 2024 EPS Estimates for Charles River Laboratories International, Inc. Decreased by Analyst (NYSE:CRL)
May 31, 2024 | marketbeat.com
Brokers Set Expectations for Charles River Laboratories International, Inc.'s Q2 2024 Earnings (NYSE:CRL)
Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) - Equities research analysts at Zacks Research reduced their Q2 2024 EPS estimates for shares of Charles River Laboratories International in a research note issued to investors on Thursday, May 30th. Zacks Research analyst R.
May 31, 2024 | seekingalpha.com
Charles River Laboratories: Fair Valuation Against Fundamentals
May 30, 2024 | businesswire.com
Charles River Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy Development
May 30, 2024 | marketbeat.com
Charles River Laboratories International Q1 Earnings Transcript
May 30, 2024 | marketbeat.com
Corient Private Wealth LLC Boosts Stake in Charles River Laboratories International, Inc. (NYSE:CRL)
Corient Private Wealth LLC raised its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 114.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 13,358 shares
May 28, 2024 | businesswire.com
Titian Receives Multi-Year Commitment from Charles River for Mosaic Sample Management Software
May 25, 2024 | marketbeat.com
428,592 Shares in Charles River Laboratories International, Inc. (NYSE:CRL) Acquired by Norges Bank
Norges Bank purchased a new stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 428,592 shares of the medical research company's stock, valued at approximately $101
May 25, 2024 | marketbeat.com
Charles River Laboratories International (NYSE:CRL) Cut to "Hold" at StockNews.com
StockNews.com cut shares of Charles River Laboratories International from a "buy" rating to a "hold" rating in a research note on Saturday.
May 24, 2024 | marketbeat.com
Dai ichi Life Insurance Company Ltd Trims Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)
Dai ichi Life Insurance Company Ltd cut its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 65.4% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 9,430 shares of the medica
May 23, 2024 | marketbeat.com
Franklin Resources Inc. Decreases Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)
Franklin Resources Inc. reduced its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 2.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 763,015 shares of the
May 22, 2024 | marketbeat.com
GW&K Investment Management LLC Increases Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL)
GW&K Investment Management LLC grew its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 21.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 55,510 shares of
May 21, 2024 | marketbeat.com
King Luther Capital Management Corp Decreases Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)
King Luther Capital Management Corp trimmed its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 4.9% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 366,834 shares of the medical research compan
May 20, 2024 | marketbeat.com
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Clearbridge Investments LLC
Clearbridge Investments LLC lowered its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 15.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,468,059 shares of
May 18, 2024 | marketbeat.com
Jackson Square Partners LLC Acquires 80,873 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Jackson Square Partners LLC increased its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 30.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 349
May 16, 2024 | marketbeat.com
Charles River Laboratories International (NYSE:CRL) Shares Down 4.1%
Charles River Laboratories International (NYSE:CRL) Stock Price Down 4.1%
May 16, 2024 | insidertrades.com
Joseph W. Laplume Sells 1,304 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) Stock
May 14, 2024 | marketbeat.com
Curi Wealth Management LLC Decreases Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)
Curi Wealth Management LLC lowered its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 17.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 40,018 shares o
May 14, 2024 | marketbeat.com
Insider Selling: Charles River Laboratories International, Inc. (NYSE:CRL) EVP Sells 1,304 Shares of Stock
Charles River Laboratories International, Inc. (NYSE:CRL - Get Free Report) EVP Joseph W. Laplume sold 1,304 shares of the stock in a transaction dated Friday, May 10th. The stock was sold at an average price of $226.97, for a total transaction of $295,968.88. Following the transaction, the executive vice president now directly owns 23,276 shares of the company's stock, valued at approximately $5,282,953.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.
May 14, 2024 | gurufocus.com
Insider Sale: EVP Joseph Laplume Sells Shares of Charles River Laboratories International Inc (CRL)
May 13, 2024 | marketbeat.com
Charles River Laboratories International (NYSE:CRL) Price Target Cut to $228.00
TD Cowen decreased their price target on shares of Charles River Laboratories International from $260.00 to $228.00 and set a "hold" rating on the stock in a research note on Monday.
May 13, 2024 | markets.businessinsider.com
Charles Rhyee Maintains Hold on Charles River Labs Amidst Revenue and Market Uncertainties
May 12, 2024 | marketbeat.com
Charles Schwab Investment Management Inc. Acquires 21,028 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Charles Schwab Investment Management Inc. grew its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 4.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 513,227 shares of the medical resear
May 11, 2024 | marketbeat.com
Mawer Investment Management Ltd. Buys 7,014 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Mawer Investment Management Ltd. boosted its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 36.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 26,025 shares of the medica
May 10, 2024 | marketbeat.com
TimesSquare Capital Management LLC Invests $7.53 Million in Charles River Laboratories International, Inc. (NYSE:CRL)
TimesSquare Capital Management LLC purchased a new stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm purchased 31,835 shares of the medical research company's stock, value
May 9, 2024 | markets.businessinsider.com
Charles River Laboratories Reaffirms FY24 Outlook; Q1 Results Top Estimates
May 9, 2024 | msn.com
Charles River Laboratories Non-GAAP EPS of $2.27 beats by $0.21, revenue of $1.01B beats by $16.54M
May 9, 2024 | finance.yahoo.com
Charles River Laboratories Announces First-Quarter 2024 Results
May 9, 2024 | finance.yahoo.com
Charles River beats first-quarter estimates, reaffirms annual forecast
May 9, 2024 | marketbeat.com
Charles River Laboratories International (NYSE:CRL) Issues FY 2024 Earnings Guidance
Charles River Laboratories International (NYSE:CRL) updated its FY 2024 earnings guidance. The company provided EPS guidance of 10.900-11.400 for the period, compared to the consensus estimate of 11.020. The company also issued revenue guidance of $4.2 billionillion-$4.3 billionillion, compared to the consensus estimate of $4.2 billionillion.
May 9, 2024 | marketbeat.com
Russell Investments Group Ltd. Grows Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)
Russell Investments Group Ltd. boosted its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 17.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor own
May 8, 2024 | marketbeat.com
Everpar Advisors LLC Takes Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Everpar Advisors LLC bought a new stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 3,884 shares of the medical research
May 7, 2024 | marketbeat.com
Charles River Laboratories International, Inc. (NYSE:CRL) Stock Holdings Lowered by National Bank of Canada FI
National Bank of Canada FI trimmed its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 15.3% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 103,774 shares of the medical research co
Get Charles River Laboratories International News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter.

Trump’s Gift Could Unleash $51 Billion in New Wealth (Ad)

In January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”.

You just have to make this simple move before July 30, 2024.

CRL Media Mentions By Week

CRL Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CRL
News Sentiment
▼
0.67

0.76
▲
Average
Medical
News Sentiment

CRL News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CRL Articles
This Week
▼
17

6
▲
CRL Articles
Average Week

Get Charles River Laboratories International News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NYSE:CRL) was last updated on 6/9/2024 by MarketBeat.com Staff

From Our Partners
Top 5 Tech Stocks to Buy for 2024
The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...
Daily Market Alerts | Sponsored
Top 5 AI Stocks to Buy for 2024
The electric vehicle boom is accelerating – and fast.
Market Moving Trends | Sponsored
No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free
Optimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...
Hedgeye | Sponsored
AI's Next Magnificent Seven
The Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.
The Oxford Club | Sponsored
Biden replacement revealed?
A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on...
Paradigm Press | Sponsored
Urgent alert: open this for a huge profit potential
This groundbreaking technology that Tim calls “Inception” isn’t being talked about anywhere… not on Fox, Yahoo...
Timothy Sykes | Sponsored
Are You Positioned For The New Energy Goldrush?
Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...
Wealthpin Pro | Sponsored
RSVP: Charles Payne’s Cash Flow Workshop
Did you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...
Unstoppable Prosperity | Sponsored